Loukianos Rallidis Selected Research

Loukianos Rallidis Research Topics

5	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2008
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2022 - 01/2016
3	Hypertension (High Blood Pressure) 12/2022 - 08/2009
2	Hypercholesterolemia 01/2023 - 01/2016
2	Myocardial Infarction 07/2022 - 07/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020 - 01/2014
1	Obesity 01/2024
1	Hypertriglyceridemia 01/2023
1	Peripheral Arterial Disease 07/2022
1	Urologic Neoplasms (Urological Cancer) 01/2022
1	Chronic Limb-Threatening Ischemia 12/2020
1	Overweight 12/2020
1	Atherosclerosis 12/2020
1	Multiple Sclerosis 01/2020
1	Pulmonary Arterial Hypertension 01/2020
1	Dyslipidemias (Dyslipidemia) 07/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Genetic Risk Score 01/2017
1	Thrombosis (Thrombus) 03/2016
1	Chronic Renal Insufficiency 01/2016
1	Coronary Disease (Coronary Heart Disease) 11/2013

4	LipidsIBA 01/2024 - 01/2014
4	oxidized low density lipoproteinIBA 01/2023 - 01/2016
3	Triglycerides (Triacylglycerol)IBA 01/2023 - 01/2018
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 07/2022 - 07/2012
2	HDL CholesterolIBA 12/2022 - 12/2020
2	LDL CholesterolIBA 12/2021 - 05/2020
2	TeaIBA 05/2019 - 01/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2014
1	omega-Chloroacetophenone (Mace)IBA 07/2022
1	Lipoprotein(a)IBA 01/2022
1	VitaminsIBA 12/2020
1	InterferonsIBA 01/2020
1	CholesterolIBA 07/2019
1	Endothelial Protein C ReceptorIBA 03/2016
1	Proprotein Convertase 9IBA 01/2016
1	Ezetimibe (Zetia)FDA Link 01/2016
1	evolocumabIBA 01/2016
1	alirocumabIBA 01/2016
1	PCSK9 InhibitorsIBA 01/2016
1	AntioxidantsIBA 01/2014
1	C-Reactive ProteinIBA 01/2014
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 11/2013
1	Protease Inhibitors (Protease Inhibitor)IBA 09/2008

2	Therapeutics 01/2020 - 08/2009
1	Drug Therapy (Chemotherapy) 01/2022
1	Nutritional Support (Artificial Feeding) 12/2020
1	Mediterranean Diet 09/2018
1	Percutaneous Coronary Intervention 07/2012